title: Point/Counterpoint. Medical use of all high activity sources should be eliminated for security concerns.
authors.affiliation: Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20852 (Tel: 240-276-5706; E-mail: capalaj@mail.nih.gov).
authors.forename: Jacek
authors.initials: J
authors.lastname: Capala
authors.affiliation: San Diego Gamma Knife Center, La Jolla, California 92037 (Tel: 858-452-5020; E-mail: stevegoetsch@sdgkc.com).
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Goetsch
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D011868:Radioisotopes; D011878:Radiotherapy / Q000295:instrumentation* / Q000379:methods*; D012306:Risk; D012637:Security Measures / Q000331:legislation & jurisprudence
chemical_list: D011868:Radioisotopes